REGENXBIO Inc. — Director's Dealing 2015

Sep 16, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2015-09-16

Reporting Person: KARABELAS ARGERIS N (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.76	2025-05-18	Common Stock (40000)		Direct

Footnotes

F1: 25% of the shares subject to the option vested on May 19, 2015. The remaining 75% of the shares subject to the option shall vest in 24 equal monthly installments thereafter. 100% of the shares shall vest upon a Change in Control of the Issuer or the death of the Optionee.